| Title |
Bisphosphonates in multiple myeloma: a network meta‐analysis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2012
|
| DOI | 10.1002/14651858.cd003188.pub3 |
| Pubmed ID | |
| Authors |
Rahul Mhaskar, Jasmina Redzepovic, Keith Wheatley, Otavio Augusto Camara Clark, Branko Miladinovic, Axel Glasmacher, Ambuj Kumar, Benjamin Djulbegovic |
| Abstract |
Bisphosphonates are specific inhibitors of osteoclastic activity and used in the treatment of patients with multiple myeloma (MM). While bisphosphonates are shown to be effective in reducing vertebral fractures and pain, their role in improving overall survival (OS) remains unclear. This is an update of a Cochrane review first published in 2002 and previously updated in 2010. |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 31% |
| United Kingdom | 3 | 19% |
| Mexico | 2 | 13% |
| Ecuador | 1 | 6% |
| Brazil | 1 | 6% |
| Spain | 1 | 6% |
| Unknown | 3 | 19% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 88% |
| Scientists | 1 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 1% |
| Netherlands | 1 | <1% |
| Egypt | 1 | <1% |
| Taiwan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 154 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 26 | 16% |
| Student > Ph. D. Student | 19 | 12% |
| Other | 16 | 10% |
| Student > Master | 15 | 9% |
| Student > Doctoral Student | 14 | 9% |
| Other | 35 | 22% |
| Unknown | 35 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 84 | 53% |
| Agricultural and Biological Sciences | 10 | 6% |
| Nursing and Health Professions | 8 | 5% |
| Economics, Econometrics and Finance | 3 | 2% |
| Mathematics | 3 | 2% |
| Other | 16 | 10% |
| Unknown | 36 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2019.
All research outputs
#1,731,677
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#3,701
of 11,499 outputs
Outputs of similar age
#9,819
of 176,582 outputs
Outputs of similar age from Cochrane database of systematic reviews
#34
of 181 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,582 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 181 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.